Novo Nordisk slashes sales forecast and profits amid US drug competitionJuly 29, 2025 Shares of Danish pharmaceutical company Novo Nordisk fell sharply by 20% on Tuesday after the company cut its full-year sales and profit outlook and named a new chief executive officer. The market reaction came amid ongoing challenges in the U.S.
